Assay Detail
Binding
CHEMBL5735876
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Human, Dog and Rat c-Fms Enzyme Assay: Materials:Human c-fms protein (N-terminal 6His-tagged, amino acids 538-972), dog c-fms protein (N-terminal 6His-tagged, amino acids 535-967) and rat c-fms protein (N-terminal 6His-tagged, amino acids 536-978) were purified in-house using a HisTrap column. The Antibody Beacon tyrosine kinase assay kit was purchased from Life Technologies. The c-fms peptide substrate, SYEGNSYTFIDPTQ, and the phosphorylated product, SYEGNSpYTFIDPTQ, were obtained from American Peptide Company. Non-binding surface (NBS) 384-well plates were obtained from Corning.c-fms Enzyme Assay Procedure:In this assay, recombinant human, dog or rat c-fms catalyzed the phosphorylation of the FMS peptide substrate, SYEGNSYTFIDPTQ, with the phosphorylated product detected by a fluorescence immunoassay. The c-fms assay buffer consisted of 25 mM HEPES, pH 7.0, 5 mM MgCl2, 1 mM DTT and 0.01% Brj-35. 5 μl of 3× of the test compound(s) in assay buffer containing 1% DMSO were added to the wells of a 384-well NBS plate, at concentrations of 1 μM down to 0.00002 μM (applying a 1:3 dilution scheme). c-fms activity was assayed in the presence of 300 μM SYEGNSYTFIDPTQ, 1 mM ATP and human, dog or rat c-fms in a total volume of 15 μl. The reaction was initiated with ATP. The assay plates were sealed with aluminum sealing tape and incubated at room temperature for 2 h. At the end of the incubation, 5 μl of 4× detection reagent were added to each well (Antibody Beacon tyrosine kinase assay kit; the 4× detection reagent consisted of 100 nM Oregon Green 488 ligand and 200 nM anti-phosphotyrosine antibody and was prepared just prior to use). The plates were centrifuged at 1000×g for 1 min. Fluorescence was measured after 10 min on a Safire II reader at excitation/emission of 492/517 nm. RFU values were converted to micromolar phosphopeptide using a SYEGNSpYTFIDPTQ standard curve. IC50 values were calculated using GraphPad Prism 5.
15
Total Activities
4
Compounds Tested
3
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Substituted pyridine derivatives useful as C-FMS kinase inhibitors
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 5 | 8.27 | 8.66 |
| kon | 5 | - | - |
| k_off | 5 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5902562 | — | — | 6 | 8.66 |
| CHEMBL5920028 | — | — | 3 | 8.60 |
| CHEMBL5756259 | — | — | 3 | 8.10 |
| CHEMBL3674570 | EDICOTINIB | 2.0 | 3 | 7.96 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5902562 | — | IC50 | = | 2.2 | nM | 8.66 |
| CHEMBL5920028 | — | IC50 | = | 2.5 | nM | 8.60 |
| CHEMBL5756259 | — | IC50 | = | 7.9 | nM | 8.10 |
| CHEMBL5902562 | — | IC50 | = | 9.6 | nM | 8.02 |
| CHEMBL3674570 | EDICOTINIB | IC50 | = | 11.0 | nM | 7.96 |
| CHEMBL5902562 | — | kon | = | - | — | - |
| CHEMBL5902562 | — | k_off | = | - | s-1 | - |
| CHEMBL5920028 | — | kon | = | - | — | - |
| CHEMBL5920028 | — | k_off | = | - | s-1 | - |
| CHEMBL5756259 | — | kon | = | - | — | - |
| CHEMBL5756259 | — | k_off | = | - | s-1 | - |
| CHEMBL5902562 | — | kon | = | - | — | - |
| CHEMBL5902562 | — | k_off | = | - | s-1 | - |
| CHEMBL3674570 | EDICOTINIB | kon | = | - | — | - |
| CHEMBL3674570 | EDICOTINIB | k_off | = | - | s-1 | - |